NCT06311227 2026-03-19Venetoclax for the Treatment of Patients With Relapsed Hairy Cell LeukemiaNational Cancer Institute (NCI)Phase 2 Recruiting20 enrolled
NCT06965114 2026-03-18Testing the Combination of Anti-cancer Drugs, Tovorafenib Plus Rituximab, in Patients With Hairy Cell LeukemiaNational Cancer Institute (NCI)Phase 1/2 Recruiting84 enrolled